BILvsLABD
SPDR Bloomberg 1-3 Month T-Bill ETF against DIREXION DAILY S&P BIOTECH BEAR 3X SHARES — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIL | LABD | |
|---|---|---|
| Expense ratio | 0.14% | — |
| Assets | $51.3B | $78M |
| Net flow, 1 month | +$3.2B | −$80M |
| Net flow, 1 year | +$8.8B | +$73M |
| Return, YTD | +0.3% | -62.9% |
| Return, 1 year | — | — |
| Avg daily volume | 12.9M | 25.7M |
| Holdings | 23 | 1 |
| Listed | May 25, 2007 | Jul 31, 2024 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS